Dr Stephen E Rawe, MD | |
2145 Henry Tecklenburg Dr, Suite 220, Charleston, SC 29414-5893 | |
(843) 723-0916 | |
(843) 722-8124 |
Full Name | Dr Stephen E Rawe |
---|---|
Gender | Male |
Speciality | Neurological Surgery |
Location | 2145 Henry Tecklenburg Dr, Charleston, South Carolina |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1235198201 | NPI | - | NPPES |
077981 | Medicaid | SC | |
P00648631 | Other | SC | MEDICARE RAILROAD |
P00803386 | Other | SC | RAILROAD MEDICARE ID-RSFPN |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207T00000X | Neurological Surgery | 7798 (South Carolina) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Stephen E Rawe, MD Po Box 751649, Charlotte, NC 28275-1649 Ph: (843) 789-1620 | Dr Stephen E Rawe, MD 2145 Henry Tecklenburg Dr, Suite 220, Charleston, SC 29414-5893 Ph: (843) 723-0916 |
News Archive
Astex Therapeutics, the UK-based biotechnology company developing targeted therapies for oncology and virology, and the Multiple Myeloma Research Consortium announced today the initiation of a Phase II clinical trial of the cyclin-dependent kinase inhibitor, AT7519, to treat patients with relapsed or refractory multiple myeloma, an incurable blood cancer. The trial is designed to investigate both single agent and combination activity of AT7519 with bortezomib (VelcadeĀ®).
Quality of life after treatment for endometrial cancer can be significantly improved by the use of vaginal brachytherapy, where radiotherapy is delivered internally using a vaginal cylinder, the European Cancer Conference (ECCO 14) heard today (Monday September 24).
According to the Australian Medical Association (AMA) every rural GP and specialist should be paid tens of thousands of dollars per year in extra incentives to encourage more to commit to country practice, warning that "urgent intervention" is required to tackle a workforce crisis.
GlaxoSmithKline believes that conclusions drawn from the most recent meta-analyses published by Drs. Nissen et. al. and Furberg et. al. in the Journal of the American Medical Association do not confirm a difference in the safety profile of Avandia (rosiglitazone) and Actos (pioglitazone).
DePuy Synthes Products, Inc., part of the Johnson & Johnson Family of Companies, has acquired 3D printing technology from Tissue Regeneration Systems, Inc. (TRS). The 3D printing methods developed by TRS will help enable DePuy Synthes to create patient-specific, bioresorbable implants with a unique mineral coating intended to support bone healing in patients with orthopaedic and craniomaxillofacial deformities and injuries. Financial terms of the transaction have not been disclosed.
› Verified 1 days ago
Dr. Matthew T Neal, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2145 Henry Tecklenburg Dr Ste 220, Charleston, SC 29414 Phone: 843-723-8823 | |
Steven Steuer Glazier, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. John D Steichen, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2145 Henry Tecklenburg Dr Ste 220, Charleston, SC 29414 Phone: 843-723-8823 Fax: 843-606-8059 | |
Ricardo Alfonso Domingo Cabreja, MD Neurological Surgery Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2424 | |
Clayton Lee Haldeman, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2145 Henry Tecklenburg Dr Ste 220, Charleston, SC 29414 Phone: 843-723-8823 | |
Dr. Sunil J Patel, MD Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Dr. Stephen Robert Lowe, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-792-1414 Fax: 843-792-9295 |